ARKG Investment Tracker position change: Decreased position in Veracyte by 5,800 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 3.54% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 1,585 shares, the number of shares held decreased 0.64% compared to the previous period and now represents 4.5% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 2,765 shares, the number of shares held decreased 0.64% compared to the previous period and now represents 1.74% of the total position.
ARKG Investment Tracker position change: Decreased position in Tempus AI by 13,140 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 8.43% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 75,870 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 3.22% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 29,780 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 1.23% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 12,655 shares, the number of shares held decreased 0.65% compared to the previous period and now represents 2.24% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 132,580 shares, the number of shares held decreased 1.29% compared to the previous period and now represents 1.11% of the total position.
ARKG Investment Tracker position change: Decreased position in Eli Lilly by 75 shares, the number of shares held decreased 0.64% compared to the previous period and now represents 1.11% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 42,300 shares, the number of shares held decreased 1.29% compared to the previous period and now represents 3.92% of the total position.